Health Care [ 5/12 ] | Biotechnology [ 25/74 ]
NASDAQ | Common Stock
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide.
Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.
It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -2.10 Decreased by -811.04% | - |
| Jul 31, 24 | -0.19 Increased by +52.31% | -0.28 Increased by +33.57% |
| May 7, 24 | -0.32 Decreased by -18.52% | -0.27 Decreased by -18.52% |
| Mar 13, 24 | -0.32 Decreased by -33.33% | -0.24 Decreased by -33.33% |
| Nov 2, 23 | -0.23 Increased by +34.29% | -0.35 Increased by +34.29% |
| Aug 2, 23 | -0.39 Decreased by -30.00% | -0.30 Decreased by -30.00% |
| May 4, 23 | -0.27 Increased by 0.00% | -0.32 Increased by +15.62% |
| Mar 14, 23 | -0.24 Increased by +11.11% | -0.37 Increased by +35.14% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 2.66 M Decreased by -4.17% | -1.44 M Increased by +31.80% | Decreased by -54.09% Increased by +28.83% |
| Jun 30, 24 | 2.86 M Increased by +76.21% | -2.11 M Increased by +39.46% | Decreased by -73.65% Increased by +65.64% |
| Mar 31, 24 | 2.29 M Decreased by -22.38% | -2.90 M Decreased by -25.22% | Decreased by -126.73% Decreased by -61.32% |
| Dec 31, 23 | 2.58 M Decreased by -13.05% | -3.07 M Decreased by -71.30% | Decreased by -119.33% Decreased by -97.01% |
| Sep 30, 23 | 2.78 M Increased by +7.52% | -2.11 M Increased by +31.69% | Decreased by -76.00% Increased by +36.47% |
| Jun 30, 23 | 1.63 M Decreased by -30.51% | -3.48 M Decreased by -32.53% | Decreased by -214.36% Decreased by -90.72% |
| Mar 31, 23 | 2.95 M Increased by +17.13% | -2.32 M Increased by +3.80% | Decreased by -78.56% Increased by +17.87% |
| Dec 31, 22 | 2.96 M Increased by +16.18% | -1.79 M Increased by +12.51% | Decreased by -60.57% Increased by +24.70% |